Stimvia

Place of work

Ostrava, Pardubice

Field

Medical devices

Stimvia is a Czech technology company that is fundamentally changing the approach to the treatment of chronic diseases of the central nervous system. Its flagship product, URIS®, is the first clinically proven completely non-invasive closed-loop neuromodulation system that can be applied both in the doctor’s office and outside the hospital setting – conveniently, intuitively and withup to 90% success rate in treating overactive bladder (OAB) and is comparable to invasive methods, but with minimal risk of side effects. This is because URIS® technology uses the principle of targeted stimulation of nerve structures, while maintaining maximum patient comfort and eliminating the need for surgical intervention or pharmacological burden. The combination of scientific precision, clinical validity and user-friendly design makes Stimvia a game changer in the field of non-invasive neuromodulation.

Our ambition is to make cutting-edge therapies available to millions of patients worldwide and to become synonymous with a new era of treatment for functional nervous system disorders.

URIS® is the first clinically proven neuromodulation system that for the first time ever enables non-invasive stimulation of the subsurface nerves to treat chronic overactive bladder (OAB) disease.

The technology also includes a mobile app that allows them to collect data and effectively optimize individual treatment parameters to meet the needs of each patient.

In June 2025, an article about Stimvia appeared in Forbes magazine.